SPL - Starwin Products Limited
Starwin Products Limited is a pharmaceutical manufacturer based in Ghana. It traces its history to 1960 when Sterling Products International, an American pharmaceutical company, incorporated a subsidiary in Ghana. In 1976, the company sold 50% of its stock to a group of Ghanaian investors. The group eventually bought the remaining shares of the company in 1987 and subsequently changed the name to Starwin Products Limited. The company's product line includes Rapinol, Asmadrin, Painoff, Paraking, milk of magnesia and liver salts.
|Last Trading Results||Growth & Valuation|
|Opening Price:||--||Earnings Per Share:||0.00|
|Day's Low Price:||--||Price/Earning Ratio:||--|
|Day's High Price:||--||Dividend Per Share:||0.00|
|Traded Volume:||0||Dividend Yield:||0%|
|Number of Deals:||--||Shares Outstanding:||259.81m|
Monetary values are quoted in Ghana Cedis (GHS) unless otherwise stated
SPL Market Performance
SPL is currently the worst performing stock on the Ghana Stock Exchange in terms of returns to investors with a year-to-date loss of 33.33%, followed by PBC (-33.33%) and MLC (-33.33%). Shareholders were also disgusted that they had gained nothing at all on their investments when dividends were last announced by Starwin Products Limited. Below is the historical trading trend of SPL, covering up to the last 10 trading sessions of activity.
Profile of Starwin Products Limited
Starwin Products Limited operates in the Health Care sector, specifically, the Pharmaceuticals & Biotechnology industry—according to the reverse Industry Classification Benchmark (ICB) taxonomy. The company's board of directors is composed of seven members whose names are listed below.
- Dr. Mensa Otabil
- Kwasi Yirenkyi
- Dr. Albert Gyan Boohene
- Dr. Esther Oduraa Offei-Aboagye
- Samuel Anthony De-Abba
- Michael Addo
- Justice Awuku Sao
|Factsheet of Starwin Products Limited|
Pharmaceuticals & Biotechnology
P. O. Box 5760, Accra-North
+233 (302) 221 788
+233 (302) 225 039
Industrial Stock Market Competitors
Starwin Products Limited, issuers of the SPL stock on the Ghana Stock Exchange, have two market competitors who are also engaged in the Health Care/Pharmaceuticals & Biotechnology industry. The table below gives you an overview of their market standing.
|AYRTN||Ayrton Drugs Manufacturing Co. Ltd.||21.50m||0.10||+0.00|
|IIL||Intravenous Infusions Limited||20.40m||0.08||+0.00|